354 - Australian technology bringing health equity to developing countries. Gadi Bichler, WeGuide & Curve Tomorrow

📺 Watch this episode on YouTube: https://youtu.be/mDqAYjiLsgo

In this episode we delve into the transformative world of no-code platforms and AI, focusing on the innovative SaaS platform - WeGuide.

If you're a healthcare professional, tech enthusiast, or anyone who has ever wondered about the potential of technology in advancing healthcare equity globally, this is for you.

Pete is joined by Gadi Bichler, Chief Strategy Officer at WeGuide & Curve Tomorrow, who shares his perspectives on the role of technology in enhancing health outcomes, particularly in the developing world.

This episode uncovers how no-code platforms like WeGuide are making significant strides in healthcare. You'll learn about their capability to streamline complex healthcare processes, manage Patient Reported Outcome Measures (PROMs) and Patient Reported Experience Measures (PREMs), and how they've been invaluable tools during the COVID-19 pandemic.

We dive deep into the possibilities that lie in the integration of AI powered no-code platforms in healthcare. We discuss how it can automate routine tasks, provide real-time analytics, and offer predictive modelling for improving patient care outcomes.

We will also unpack how WeGuide recently won Australia's largest public health tender for ECPs, highlighting the growing significance of these digital pathways, and explore how platforms like WeGuide can enable patients to play a more active role in their care, leading to better overall health outcomes.

And lots more.

Check out the episode and full show notes here.

To see the latest information, news, events and jobs on offer at WeGuide and Curve Tomorrw, visit their Talking HealthTech Directory here.

Loving the show? Leave us a review, and share it with someone who might get some value from it.

Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.